Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9100078rdf:typepubmed:Citationlld:pubmed
pubmed-article:9100078lifeskim:mentionsumls-concept:C0013227lld:lifeskim
pubmed-article:9100078lifeskim:mentionsumls-concept:C0012655lld:lifeskim
pubmed-article:9100078lifeskim:mentionsumls-concept:C0033809lld:lifeskim
pubmed-article:9100078lifeskim:mentionsumls-concept:C0370003lld:lifeskim
pubmed-article:9100078lifeskim:mentionsumls-concept:C0205409lld:lifeskim
pubmed-article:9100078lifeskim:mentionsumls-concept:C0449943lld:lifeskim
pubmed-article:9100078lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:9100078pubmed:issue2lld:pubmed
pubmed-article:9100078pubmed:dateCreated1997-5-30lld:pubmed
pubmed-article:9100078pubmed:abstractTextBetween January, 1982 and December, 1994, 236 Pseudomonas aeruginosa strains were isolated from clinical specimens at our division, and were tested for serotypes and drug-susceptibilities to 15 antibiotics. Serotype G strains were isolated at the highest frequency (32.6%), and followed by strains of serotype B (15.7%), A (11.9%), E (9.3%), I (7.2%), F and M (5.5%), non-typable (5.1%), D (3.4%), H (2.1%), C and K (0.8%). We examined the changes of isolation frequencies of different serotypes annually. Isolation frequencies of serotypes E and F showed tendency to decrease, whereas serotype I has been isolated increasingly year by year. MIC90's of the 15 antibiotics were as follows, tosufloxacin: 0.78 microgram/ml, biapenem (BIPM) and ofloxacin (OFLX): 3.13 micrograms/ml, imipenem (IPM), ceftazidime, cefozopran, cefsulodin and gentamicin: 6.25 micrograms/ml, aztreonam and amikacin: 12.5 micrograms/ml, piperacillin, cefoperazone and minocycline (MINO): 25 micrograms/ml, fosfomycin: > 100 micrograms/ml and chloramphenicol: > 200 micrograms/ml. MIC90'S of IPM, BIPM, MINO and OFLX increased 4-fold from stage I (1982-1987) through stage III (1992-1994) and the isolation frequency of drug-resistant strains increased year by year. In other words, antibiotic resistant strains appeared increasing with time. No relationship between serotypes and drug-resistance were observed.lld:pubmed
pubmed-article:9100078pubmed:languagejpnlld:pubmed
pubmed-article:9100078pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9100078pubmed:citationSubsetIMlld:pubmed
pubmed-article:9100078pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9100078pubmed:statusMEDLINElld:pubmed
pubmed-article:9100078pubmed:monthFeblld:pubmed
pubmed-article:9100078pubmed:issn0368-2781lld:pubmed
pubmed-article:9100078pubmed:authorpubmed-author:HasegawaYYlld:pubmed
pubmed-article:9100078pubmed:authorpubmed-author:SasakiHHlld:pubmed
pubmed-article:9100078pubmed:authorpubmed-author:ShibasakiKKlld:pubmed
pubmed-article:9100078pubmed:authorpubmed-author:OsakaKKlld:pubmed
pubmed-article:9100078pubmed:authorpubmed-author:YasuiHHlld:pubmed
pubmed-article:9100078pubmed:authorpubmed-author:NakaeMMlld:pubmed
pubmed-article:9100078pubmed:authorpubmed-author:ImaiCClld:pubmed
pubmed-article:9100078pubmed:authorpubmed-author:SugaharaYYlld:pubmed
pubmed-article:9100078pubmed:issnTypePrintlld:pubmed
pubmed-article:9100078pubmed:volume50lld:pubmed
pubmed-article:9100078pubmed:ownerNLMlld:pubmed
pubmed-article:9100078pubmed:authorsCompleteYlld:pubmed
pubmed-article:9100078pubmed:pagination187-94lld:pubmed
pubmed-article:9100078pubmed:dateRevised2009-11-11lld:pubmed
pubmed-article:9100078pubmed:meshHeadingpubmed-meshheading:9100078-...lld:pubmed
pubmed-article:9100078pubmed:meshHeadingpubmed-meshheading:9100078-...lld:pubmed
pubmed-article:9100078pubmed:meshHeadingpubmed-meshheading:9100078-...lld:pubmed
pubmed-article:9100078pubmed:meshHeadingpubmed-meshheading:9100078-...lld:pubmed
pubmed-article:9100078pubmed:year1997lld:pubmed
pubmed-article:9100078pubmed:articleTitle[Serotypes and drug susceptibility of Pseudomonas aeruginosa isolated from clinical specimens].lld:pubmed
pubmed-article:9100078pubmed:affiliationDepartment of Clinical Laboratory, Nippon Dental University, School of Dentistry at Niigata.lld:pubmed
pubmed-article:9100078pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9100078pubmed:publicationTypeEnglish Abstractlld:pubmed